Health
Eli Lilly oral GLP-1 'Foundayo' FDA approved; pill era begins
Orforglipron (Foundayo) earned FDA approval April 1 as first oral GLP-1 with no food/water restrictions. ATTAIN-1 trial showed 72-week 12.4% weight loss. Launched April 6 via Lilly Direct.
Primary sources · 2
Related storylines